279 related articles for article (PubMed ID: 22433652)
21. Mesenchymal stem cell therapy for cardiac repair.
Boyle AJ; McNiece IK; Hare JM
Methods Mol Biol; 2010; 660():65-84. PubMed ID: 20680813
[TBL] [Abstract][Full Text] [Related]
22. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
Le Blanc K; Ringdén O
Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
[TBL] [Abstract][Full Text] [Related]
23. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.
Lim SY; Kim YS; Ahn Y; Jeong MH; Hong MH; Joo SY; Nam KI; Cho JG; Kang PM; Park JC
Cardiovasc Res; 2006 Jun; 70(3):530-42. PubMed ID: 16563361
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
25. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
Tang J; Xie Q; Pan G; Wang J; Wang M
Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
[TBL] [Abstract][Full Text] [Related]
26. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
[TBL] [Abstract][Full Text] [Related]
27. The Importance of HLA Assessment in "Off-the-Shelf" Allogeneic Mesenchymal Stem Cells Based-Therapies.
Kot M; Baj-Krzyworzeka M; Szatanek R; Musiał-Wysocka A; Suda-Szczurek M; Majka M
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766164
[TBL] [Abstract][Full Text] [Related]
28. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model.
Wan CD; Cheng R; Wang HB; Liu T
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):29-33. PubMed ID: 18234635
[TBL] [Abstract][Full Text] [Related]
30. Transplantation of magnetically labeled mesenchymal stem cells improves cardiac function in a swine myocardial infarction model.
Qi CM; Ma GS; Liu NF; Shen CX; Chen Z; Liu XJ; Hu YP; Zhang XL; Teng GJ; Ju SH; Ma M; Tang YL
Chin Med J (Engl); 2008 Mar; 121(6):544-50. PubMed ID: 18364144
[TBL] [Abstract][Full Text] [Related]
31. Focused ultrasound-induced stimulation of microbubbles augments site-targeted engraftment of mesenchymal stem cells after acute myocardial infarction.
Ghanem A; Steingen C; Brenig F; Funcke F; Bai ZY; Hall C; Chin CT; Nickenig G; Bloch W; Tiemann K
J Mol Cell Cardiol; 2009 Sep; 47(3):411-8. PubMed ID: 19540842
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
Müller I; Lymperi S; Dazzi F
Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
[TBL] [Abstract][Full Text] [Related]
33. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats.
Hou M; Yang KM; Zhang H; Zhu WQ; Duan FJ; Wang H; Song YH; Wei YJ; Hu SS
Int J Cardiol; 2007 Feb; 115(2):220-8. PubMed ID: 16889848
[TBL] [Abstract][Full Text] [Related]
34. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits.
Tan MY; Zhi W; Wei RQ; Huang YC; Zhou KP; Tan B; Deng L; Luo JC; Li XQ; Xie HQ; Yang ZM
Biomaterials; 2009 Jul; 30(19):3234-40. PubMed ID: 19261327
[TBL] [Abstract][Full Text] [Related]
35. Stem cells in cardiac repair.
Henning RJ
Future Cardiol; 2011 Jan; 7(1):99-117. PubMed ID: 21174514
[TBL] [Abstract][Full Text] [Related]
36. Immune properties of mesenchymal stem cells.
Sotiropoulou PA; Papamichail M
Methods Mol Biol; 2007; 407():225-43. PubMed ID: 18453259
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of phosphoinositide-3-kinase class II alpha enhances mesenchymal stem cell survival in infarcted myocardium.
Eun LY; Song BW; Cha MJ; Song H; Kim IK; Choi E; Chang W; Lim S; Choi EJ; Ham O; Lee SY; Byun KH; Jang Y; Hwang KC
Biochem Biophys Res Commun; 2010 Nov; 402(2):272-9. PubMed ID: 20937252
[TBL] [Abstract][Full Text] [Related]
38. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
Yi T; Song SU
Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
[TBL] [Abstract][Full Text] [Related]
39. Concise review: mesenchymal stromal cells: potential for cardiovascular repair.
Psaltis PJ; Zannettino AC; Worthley SG; Gronthos S
Stem Cells; 2008 Sep; 26(9):2201-10. PubMed ID: 18599808
[TBL] [Abstract][Full Text] [Related]
40. Opportunities and challenges for mesenchymal stem cell-mediated heart repair.
Atsma DE; Fibbe WE; Rabelink TJ
Curr Opin Lipidol; 2007 Dec; 18(6):645-9. PubMed ID: 17993810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
